Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2018 / Cilt: 52 - Sayı: 1

The Value of the Tei Index in Predicting Implantable Cardioverter Defibrillator Shocks

Pages
36–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Tei index is a simple method to predict ICD shocks.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: An implantable cardioverter defibrillator (ICD) decreases the risk of sudden death in the appropriate patients.
📊
Key Findings & Data:However, a relationship between ICD shocks and increased mortality and morbidity has been suspected.
💡
Conclusion & Impact:The Tei index is a simple method to predict ICD shocks.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: An implantable cardioverter defibrillator (ICD) decreases the risk of sudden death in the appropriate patients. However, a relationship between ICD shocks and increased mortality and morbidity has been suspected. This report is an investigation of an association between ICD shocks and the Tei index, an echocardiographic parameter now commonly used to predict cardiovascular events.Methods: The basic characteristics of 250 patients with chronic heart failure who had an ICD implanted and 2 years of follow-up device recordings were retrospectively analyzed. Patients who received shock therapy during follow-up were compared with those who did not, based on demographic and other characteristics and the Tei index.Results: The mean Tei index value of ICD shock recipients was significantly higher than the score of non-recipients of ICD shock (0.70±0.10 vs 0.56±0.10; p<0.001). The percentage of patients for whom it was primary prevention who received either appropriate or inappropriate ICD shocks was 28.9%, whereas in those who received an ICD for secondary prevention, the percentage was 71.1% (p<0.001). ICD shock recipient patients were older, and had a greater rate of hypertension and smoking pack-years compared with those to whom an ICD shock was not delivered (p<0.001).Conclusion: The results of this study demonstrated a relationship between the Tei index and ICD shocks, either appropriate or inappropriate. The Tei index is a simple method to predict ICD shocks.

🔖

Cite This Article

SEYİS, A. S. (2018). The Value of the Tei Index in Predicting Implantable Cardioverter Defibrillator Shocks. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 52 - Sayı: 1, 36–40. https://ajindex.com/articles/363717

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40
  2. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83
  3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83
  4. Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999;22:481-9
  5. Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart Lung 2013;42:105-11
  6. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-9
  7. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105:589-94
  8. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, et al.; Sudden Cardiac Death in Heart Failure Trial Investigators. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008
  9. Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ. Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs 2009;9:393-400
  10. Block M, Breithardt G. Long term follow -up and clinical results of implantable caridoverter - defibrillators. Cardiac Electrophysiology -From Cell to Bedside. Phileadelphia: W.B. Saunders;1995;1412-25
  11. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective